Clinical Trials Logo

Recurrent Peritoneal Cancer clinical trials

View clinical trials related to Recurrent Peritoneal Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT02785250 Recruiting - Clinical trials for Recurrent Fallopian Tube Cancer

Study of DPX-Survivac Vaccine Therapy and Epacadostat in Patients With Recurrent Ovarian Cancer

Start date: April 2016
Phase: Phase 1
Study type: Interventional

Immunotherapeutic survivin vaccine DPX-Survivac, low dose oral cyclophosphamide, and IDO1 inhibitor epacadostat will be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the safety and potential immune-modulating activity of the combination of these agents.